ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Vermont » Internal Medicine

Top Internal Medicine Prescribers in Vermont

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FRANK MEIERDIERCKS MD

Internal Medicine

4,476

$225K

271
209 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $63

BRIAN KILPATRICK MD

Internal Medicine

4,333

$292K

257
194 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $63

PETER GUNTHER M.D.

Internal Medicine

4,284

$469K

284
217 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$109
Average prescription price

Avg: $63

BRENDAN BUCKLEY MD

Internal Medicine

4,127

$275K

287
217 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

5%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$67
Average prescription price

Avg: $63

STEVEN ANISMAN MD

Internal Medicine

4,053

$192K

405
340 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $63

DAVID SISCHY M.D.

Internal Medicine

3,928

$256K

294
249 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $63

MARK JEWETT M.D.

Internal Medicine

3,926

$271K

164
121 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$69
Average prescription price

Avg: $63

JAMES CURRIE MD

Internal Medicine

3,914

$254K

244
155 are 65+

15%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $63

BEACH CONGER MD

Internal Medicine

3,858

$221K

255
189 are 65+

14%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $63

H SPENCER MD

Internal Medicine

3,817

$249K

220
189 are 65+

9%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$65
Average prescription price

Avg: $63

CAROL SALAZAR M.D.

Internal Medicine

3,705

$206K

113
98 are 65+

17%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $63

AMY ROBERTS MD

Internal Medicine

3,673

$165K

187
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $63

J ARTHUR GLEINER MD

Internal Medicine

3,660

$220K

189
158 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

12%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$60
Average prescription price

Avg: $63

DENNIS BEATTY M.D.

Internal Medicine

3,654

$274K

291
234 are 65+

12%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$75
Average prescription price

Avg: $63

JOHN MILLER MD

Internal Medicine

3,606

$245K

251
171 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $63

JENNIFER GILWEE MD

Internal Medicine

3,576

$202K

231
193 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

7%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $63

MELISSA BRANDES M.D.

Internal Medicine

3,492

$320K

184
136 are 65+

21%
patients receiving schedule two controlled substances

Avg: 10%

9%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 22%

$92
Average prescription price

Avg: $63

MARLENE SACHS MD

Internal Medicine

3,488

$252K

212
173 are 65+

7%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$72
Average prescription price

Avg: $63

JASON GRAMLING MD

Internal Medicine

3,475

$283K

231
193 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$81
Average prescription price

Avg: $63

DENNIS PLANTE MD

Internal Medicine

3,377

$232K

221
190 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$69
Average prescription price

Avg: $63

FRANK PROVATO MD

Internal Medicine

3,331

$188K

193
134 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

8%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $63

ALICIA CUNNINGHAM MD

Internal Medicine

3,304

$210K

232
191 are 65+

10%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$64
Average prescription price

Avg: $63

MARILYN HART MD

Internal Medicine

3,277

$151K

186
169 are 65+

8%
patients receiving schedule two controlled substances

Avg: 10%

6%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$46
Average prescription price

Avg: $63

DEBORAH SCOTT MD

Internal Medicine

3,232

$191K

185
130 are 65+

11%
patients receiving schedule two controlled substances

Avg: 10%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $63

CAROL VASSAR MD

Internal Medicine

3,222

$140K

125
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 10%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$44
Average prescription price

Avg: $63

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank